LaserSight's ADK
This article was originally published in The Gray Sheet
Executive Summary
Orlando, Florida-based firm's automated disposable keratome device will be incorporated sometime this year into CRS Clinical Research's study on laser in-situ keratomileusis (LASIK) for treatment of myopia, astigmatism and hyperopia, the firm reports March 24. LaserSight claims the study, which encompasses more than 250 surgeons, represents the largest U.S. trial ever conducted under an FDA-approved IDE. Keratomes are surgical tools used to create a thin corneal flap during refractive surgery